APA (7th ed.) Citation

B, C., EL, B., BL, C., BE, S., JS, H., DT, R., . . . MD, L. (2022). Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. BMC gastroenterology, 22(1), 71. https://doi.org/10.1186/s12876-022-02143-x

Chicago Style (17th ed.) Citation

B, Click, et al. "Objective Disease Activity Assessment and Therapeutic Drug Monitoring Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD." BMC Gastroenterology 22, no. 1 (2022): 71. https://doi.org/10.1186/s12876-022-02143-x.

MLA (9th ed.) Citation

B, Click, et al. "Objective Disease Activity Assessment and Therapeutic Drug Monitoring Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD." BMC Gastroenterology, vol. 22, no. 1, 2022, p. 71, https://doi.org/10.1186/s12876-022-02143-x.